TW201334779A - 糖尿病的治療藥 - Google Patents
糖尿病的治療藥 Download PDFInfo
- Publication number
- TW201334779A TW201334779A TW102102886A TW102102886A TW201334779A TW 201334779 A TW201334779 A TW 201334779A TW 102102886 A TW102102886 A TW 102102886A TW 102102886 A TW102102886 A TW 102102886A TW 201334779 A TW201334779 A TW 201334779A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- therapeutic
- prophylactic agent
- diabetes
- glucose metabolism
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012015351 | 2012-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201334779A true TW201334779A (zh) | 2013-09-01 |
Family
ID=48873581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102102886A TW201334779A (zh) | 2012-01-27 | 2013-01-25 | 糖尿病的治療藥 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150005506A1 (en, 2012) |
| EP (1) | EP2808018B1 (en, 2012) |
| JP (1) | JP5924699B2 (en, 2012) |
| KR (1) | KR20140134266A (en, 2012) |
| CN (1) | CN104066430A (en, 2012) |
| AR (1) | AR089812A1 (en, 2012) |
| AU (1) | AU2013212865A1 (en, 2012) |
| BR (1) | BR112014017902A2 (en, 2012) |
| CA (1) | CA2862602A1 (en, 2012) |
| HK (1) | HK1201209A1 (en, 2012) |
| IN (1) | IN2014DN05972A (en, 2012) |
| MX (1) | MX2014008484A (en, 2012) |
| RU (1) | RU2014134845A (en, 2012) |
| TW (1) | TW201334779A (en, 2012) |
| WO (1) | WO2013111870A1 (en, 2012) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104628671B (zh) * | 2015-02-10 | 2016-04-13 | 佛山市赛维斯医药科技有限公司 | 含苯基脒结构的硝基苯噻唑羧酸酰胺类化合物及用途 |
| CN104628672A (zh) * | 2015-02-10 | 2015-05-20 | 佛山市赛维斯医药科技有限公司 | 一类含苯基脒结构的烷氧苯基噻唑羧酸酰胺类化合物及用途 |
| CN104628673A (zh) * | 2015-02-10 | 2015-05-20 | 佛山市赛维斯医药科技有限公司 | 一类含叔丁基脒结构的腈基苯噻唑羧酸酰胺类化合物及用途 |
| CN104610188B (zh) * | 2015-02-10 | 2016-07-27 | 佛山市赛维斯医药科技有限公司 | 含苯基脒结构的腈基苯噻唑羧酸酰胺类化合物、其制备及用途 |
| CN104610190B (zh) * | 2015-02-10 | 2016-08-17 | 佛山市赛维斯医药科技有限公司 | 一类含环丙基脒结构的卤代苯基噻唑羧酸酰胺类化合物及用途 |
| KR102473677B1 (ko) * | 2015-08-17 | 2022-12-02 | 삼성디스플레이 주식회사 | 액정 표시 장치 |
| CN109069490B (zh) | 2016-02-19 | 2021-07-16 | 上海根乃津药业科技有限公司 | 痴呆症治疗药或预防药 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG86971A1 (en) * | 1990-11-30 | 2002-03-19 | Teijin Ltd | 2-arylthiazole derivatives and pharmaceutical composition thereof |
| HUP9902721A2 (hu) * | 1997-11-25 | 1999-12-28 | The Procter & Gamble Co. | Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület |
| US20050074442A1 (en) * | 2002-03-13 | 2005-04-07 | Natarajan Ranganathan | Compositions and methods for augmenting kidney function |
| JP2008506785A (ja) * | 2004-07-21 | 2008-03-06 | フロリダ大学 リサーチファウンデーション インコーポレイティッド | インスリン抵抗性の治療及び予防のための組成物及び方法 |
| JP2009501795A (ja) * | 2005-07-21 | 2009-01-22 | ユニバーシティ オブ フロリダ リサーチファウンデーション インコーポレイティッド | 高尿酸血に関連する健康状態の治療及び予防のための組成物及び方法 |
| CA2617248C (en) | 2005-08-03 | 2015-09-29 | Tap Pharmaceutical Products, Inc. | Methods for treating hypertension |
| JP2009516691A (ja) * | 2005-11-21 | 2009-04-23 | タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド | Ｑｔ間隔延長およびこれに伴う疾病の治療 |
| JP2007210978A (ja) * | 2006-02-13 | 2007-08-23 | Hiroshima Univ | 耐糖能障害、ｉｉ型糖尿病、高脂血症、メタボリックシンドローム、内臓脂肪型肥満、脂肪肝または非アルコール性脂肪性肝炎の予防・治療剤 |
| JP2010509372A (ja) | 2006-11-13 | 2010-03-25 | タケダ・フアーマシユーテイカルズ・ノース・アメリカ・インコーポレイテツド | キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法 |
| KR101411806B1 (ko) * | 2007-11-27 | 2014-06-24 | 아디아 바이오사이언스즈 인크. | 신규한 화합물 및 조성물과 사용 방법 |
| US8394792B2 (en) * | 2008-03-31 | 2013-03-12 | C&C Research Laboratories | Heterocyclic derivatives |
| BRPI0910541B8 (pt) * | 2008-04-30 | 2021-05-25 | Wellstat Therapeutics Corp | compostos de tetrazol |
| ES2526930T3 (es) * | 2008-05-22 | 2015-01-16 | Astrazeneca Ab | Método para el tratamiento de la hiperuricemia empleando un inhibidor de SGLT2 y composición que contiene el mismo |
| CN102256488A (zh) * | 2008-10-19 | 2011-11-23 | 理查德·J·约翰逊 | 伴随代谢失衡慢性肾病的治疗组合物和治疗方法 |
| WO2011022757A1 (en) * | 2009-08-24 | 2011-03-03 | Queensland University Of Technology | Purine-targeted diagnosis and therapy of wounds |
| PE20130574A1 (es) * | 2010-06-16 | 2013-06-01 | Takeda Pharmaceuticals Usa Inc | Nuevas formas de dosificacion de liberacion modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa |
| EP2586442A4 (en) * | 2010-06-25 | 2014-01-01 | Teijin Pharma Ltd | THERAPEUTICS WITH DELAYED RELEASE FOR BLOOD HIGH PRESSURE AND KIDNEY FUNCTIONAL DISORDER |
-
2013
- 2013-01-25 AU AU2013212865A patent/AU2013212865A1/en not_active Abandoned
- 2013-01-25 IN IN5972DEN2014 patent/IN2014DN05972A/en unknown
- 2013-01-25 HK HK15101890.2A patent/HK1201209A1/xx unknown
- 2013-01-25 AR ARP130100233A patent/AR089812A1/es unknown
- 2013-01-25 EP EP13740913.2A patent/EP2808018B1/en not_active Not-in-force
- 2013-01-25 KR KR1020147020342A patent/KR20140134266A/ko not_active Withdrawn
- 2013-01-25 US US14/372,961 patent/US20150005506A1/en not_active Abandoned
- 2013-01-25 CA CA2862602A patent/CA2862602A1/en not_active Abandoned
- 2013-01-25 TW TW102102886A patent/TW201334779A/zh unknown
- 2013-01-25 BR BR112014017902A patent/BR112014017902A2/pt not_active IP Right Cessation
- 2013-01-25 RU RU2014134845A patent/RU2014134845A/ru not_active Application Discontinuation
- 2013-01-25 CN CN201380006730.6A patent/CN104066430A/zh active Pending
- 2013-01-25 WO PCT/JP2013/051627 patent/WO2013111870A1/ja active Application Filing
- 2013-01-25 JP JP2013555326A patent/JP5924699B2/ja not_active Expired - Fee Related
- 2013-01-25 MX MX2014008484A patent/MX2014008484A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1201209A1 (en) | 2015-08-28 |
| AU2013212865A1 (en) | 2014-08-14 |
| CN104066430A (zh) | 2014-09-24 |
| JPWO2013111870A1 (ja) | 2015-05-11 |
| RU2014134845A (ru) | 2016-03-20 |
| US20150005506A1 (en) | 2015-01-01 |
| MX2014008484A (es) | 2014-10-14 |
| AR089812A1 (es) | 2014-09-17 |
| KR20140134266A (ko) | 2014-11-21 |
| JP5924699B2 (ja) | 2016-05-25 |
| WO2013111870A1 (ja) | 2013-08-01 |
| EP2808018B1 (en) | 2018-03-14 |
| EP2808018A1 (en) | 2014-12-03 |
| EP2808018A4 (en) | 2015-07-15 |
| BR112014017902A2 (pt) | 2017-08-22 |
| CA2862602A1 (en) | 2013-08-01 |
| IN2014DN05972A (en, 2012) | 2015-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW201334779A (zh) | 糖尿病的治療藥 | |
| UA100119C2 (uk) | Застосування 3-альфа-андростандіолу в поєднанні з агоністом 5-ht1а для лікування сексуальної дисфункції | |
| US11497748B2 (en) | Method for activating AMPK and the use of adenine | |
| JP2016529307A (ja) | アルツハイマー病の処置に使用するためのｈ３受容体アンタゴニスト | |
| JP5680412B2 (ja) | レオヌリンの使用およびその組成物 | |
| TWI777059B (zh) | 肌肉減少症之預防劑及治療劑 | |
| JP6499634B2 (ja) | 過活動膀胱の治療のためのソリフェナシンと唾液分泌刺激剤の組合せ | |
| JPWO2007007757A1 (ja) | ＰＰＡＲγアゴニストを含有する医薬組成物 | |
| JP7357380B2 (ja) | 肥満関連代謝疾患の改善剤 | |
| JP2004244409A (ja) | 糖尿病の発症予防薬 | |
| JP2014513689A (ja) | 過活動膀胱の治療のためのトロスピウムと唾液分泌刺激剤の組合せ | |
| JP2020143037A (ja) | 糖尿病合併心不全の治療用医薬組成物 | |
| US20100324081A1 (en) | Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient | |
| JP2002145767A (ja) | 循環器疾患治療剤および健康食品 | |
| KR20100017460A (ko) | 피피에이알 감마 작용물질로 인한 부작용의 예방에 유용한 조성물 | |
| WO2010098475A1 (ja) | 摂食障害予防及び治療剤 | |
| JP6861726B2 (ja) | 糖尿病性腎症の治療薬または予防薬 | |
| WO2023014748A1 (en) | Nitrated fatty acids for the treatment of sickle cell disorders | |
| WO2007123126A1 (ja) | 慢性心不全における運動耐容能低下の改善剤 | |
| WO2015046857A1 (ko) | 자가면역성 갑상선 질환의 예방 또는 치료용 조성물 | |
| JP2007530643A (ja) | 複素環化合物と抗酸化剤との組合わせ、および肥満症を処置するためのその使用 | |
| JPWO2019225722A1 (ja) | 代謝改善剤 | |
| JP2008179574A (ja) | ピペラジン誘導体を有効成分とする糖化最終産物形成阻害剤 | |
| JP2008273859A (ja) | 腎機能障害を持つ心不全患者を治療するためのコハク酸シベンゾリンを有効成分とする不整脈治療剤 | |
| JP2004067513A (ja) | キノン系肝疾患治療剤 |